Varda Raises $187 Million to Revolutionize Drug Manufacturing in Space

Space startup Varda raised $187 million in Series C funding led by Natural Capital and Shrug Capital. Investors include Peter Thiel, Lux Capital, and Khosla Ventures. Varda aims to advance drug manufacturing in space to create drugs that crystallize differently in orbit. The company has completed three space launches and plans to launch a fifth by year-end. Varda is the first company to process materials outside the International Space Station.

Read more at CNBC: Space startup Varda raises $187 million to make drugs in orbit